Answers are grounded in this paper and cite their sources.
Quercetin (QCT), one of the most potent flavonoids found in many fruits, vegetables and plants has gained appreciable attention for its antioxidant, anti-inflammatory and wound-healing properties, making it a promising candidate for topical formulations. However, low aqueous solubility, poor permeability and instability in physiological media have limited its widespread application in the pharmaceutical field. The objective of this investigation was to design and examine a novel drug delivery system combining quercetin-loaded transferosomes in a thuja oil emulgel (QCT-TFs-TOE) for enhanced anti-inflammatory effects. TFs containing QCT were formulated using an adapted ethanol injection method and analyzed for their particle dimensions, drug encapsulation capacity, surface charge and structural appearance. The optimized TFs were incorporated in to TOE and evaluated for physicochemical properties, stability, drug release kinetics, skin permeation and anti-inflammatory efficacy. The developed formulation exhibited spherical vesicles with average size of 118 ± 0.56 nm, encapsulation efficiency of 90.35 ± 0.24 % and zeta potential of −31.1 ± 0.15 mV. The emulgel demonstrated appropriate viscosity, pH, spreadability and homogeneity with sustained QCT release. Molecular docking using AutoDock 4.2 confirmed the synergistic effect of QCT and thuja oil in the form of TFs and emulgel. In vitro anti-inflammatory assay performed on RWA 264.7 cell lines showed 72.68 % inhibition of QCT-TFs-TOE in comparison to plain QCT gel with 38.94 % inhibition. This innovative co-delivery of QCT-TFs-TOE represented a promising alternative treatment strategy approach for topical delivery with enhanced anti-inflammatory efficacy.
No takes yet. Share an insight, caveat, or question.
Mali et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: